BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 12459331)

  • 1. Production of clinical-grade recombinant adeno-associated virus vectors.
    Snyder RO; Flotte TR
    Curr Opin Biotechnol; 2002 Oct; 13(5):418-23. PubMed ID: 12459331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adeno-associated virus-based vectors in gene therapy.
    Tal J
    J Biomed Sci; 2000; 7(4):279-91. PubMed ID: 10895050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of recombinant adeno-associated virus vectors.
    Zolotukhin S
    Hum Gene Ther; 2005 May; 16(5):551-7. PubMed ID: 15916480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus vectors in clinical trials.
    Carter BJ
    Hum Gene Ther; 2005 May; 16(5):541-50. PubMed ID: 15916479
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant adeno-associated virus vectors for gene therapy.
    Conlon TJ; Flotte TR
    Expert Opin Biol Ther; 2004 Jul; 4(7):1093-101. PubMed ID: 15268676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication-defective genomic herpes simplex vectors: design and production.
    Burton EA; Bai Q; Goins WF; Glorioso JC
    Curr Opin Biotechnol; 2002 Oct; 13(5):424-8. PubMed ID: 12459332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recombinant adeno-associated virus vector related impurities].
    Diao Y; Wang Q; Xiao W; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):717-23. PubMed ID: 21845838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and purification of recombinant adeno-associated vectors.
    Wang L; Blouin V; Brument N; Bello-Roufai M; Francois A
    Methods Mol Biol; 2011; 807():361-404. PubMed ID: 22034039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
    Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
    Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No false start for novel pseudotyped vectors.
    Sanders DA
    Curr Opin Biotechnol; 2002 Oct; 13(5):437-42. PubMed ID: 12459334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in lentiviral vector design for gene-modification of hematopoietic stem cells.
    Logan AC; Lutzko C; Kohn DB
    Curr Opin Biotechnol; 2002 Oct; 13(5):429-36. PubMed ID: 12459333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.
    Flotte TR; Zeitlin PL; Reynolds TC; Heald AE; Pedersen P; Beck S; Conrad CK; Brass-Ernst L; Humphries M; Sullivan K; Wetzel R; Taylor G; Carter BJ; Guggino WB
    Hum Gene Ther; 2003 Jul; 14(11):1079-88. PubMed ID: 12885347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors.
    Mohiuddin I; Loiler S; Zolotukhin I; Byrne BJ; Flotte TR; Snyder RO
    Mol Ther; 2005 Feb; 11(2):320-6. PubMed ID: 15668144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosafety of recombinant adeno-associated virus vectors.
    Dismuke DJ; Tenenbaum L; Samulski RJ
    Curr Gene Ther; 2013 Dec; 13(6):434-52. PubMed ID: 24195602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice.
    Vidović D; Carlon MS; da Cunha MF; Dekkers JF; Hollenhorst MI; Bijvelds MJ; Ramalho AS; Van den Haute C; Ferrante M; Baekelandt V; Janssens HM; De Boeck K; Sermet-Gaudelus I; de Jonge HR; Gijsbers R; Beekman JM; Edelman A; Debyser Z
    Am J Respir Crit Care Med; 2016 Feb; 193(3):288-98. PubMed ID: 26509335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Integration of AAV vectors and insertional mutagenesis].
    Rossi A; Salvetti A
    Med Sci (Paris); 2016 Feb; 32(2):167-74. PubMed ID: 26936174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays.
    Buck TM; Wijnholds J
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus and adeno-associated virus vectors.
    Lai CM; Lai YK; Rakoczy PE
    DNA Cell Biol; 2002 Dec; 21(12):895-913. PubMed ID: 12573049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors.
    Bertran J; Miller JL; Yang Y; Fenimore-Justman A; Rueda F; Vanin EF; Nienhuis AW
    J Virol; 1996 Oct; 70(10):6759-66. PubMed ID: 8794313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrafiltered recombinant AAV8 vector can be safely administered in vivo and efficiently transduces liver.
    Kleven MD; Gomes MM; Wortham AM; Enns CA; Kahl CA
    PLoS One; 2018; 13(4):e0194728. PubMed ID: 29621273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.